首页 | 本学科首页   官方微博 | 高级检索  
     


Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
Authors:Sharon L. Sanborn  Joseph Gibbons  Smitha Krishnamurthi  Joanna M. Brell  Afshin Dowlati  Joseph A. Bokar  Charles Nock  Nancy Horvath  Jacob Bako  Scot C. Remick  Matthew M. Cooney
Affiliation:1. Division of Hematology and Oncology, MetroHealth Medical Center, Case Western Reserve University, 2500 MetroHealth Drive, Cancer Care Center, Cleveland, OH, 44109, USA
2. Division of Hematology and Oncology, University Hospitals Case Medical Center, Case Comprehensive Cancer Center, 11100 Euclid Avenue, Lakeside 1200, Cleveland, OH, 44106, USA
3. Mary Babb Randolph Cancer Center, West Virginia University, 1801 Health Sciences South, P.O. Box 9300, Morgantown, WV, 26506, USA
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号